Company intelligence / Profile preview

Enginprime Medical

Hangzhou, Zhejiang, China

Ownership: Private
Development stage: Other

Overview

Enginprime Medical is a medical technology company specializing in the development of next-generation percutaneous ventricular assist devices (pVAD). Founded in 2023 and headquartered in Hangzhou, China, the company was incubated by Voyagers Capital to address unmet needs in the cardiovascular field. Its flagship product, OpusOne™, is a low-profile pVAD designed to provide high-flow hemodynamic support for patients with heart failure or those undergoing high-risk percutaneous coronary interventions. The device features a unique foldable impeller design and integrated monitoring systems to improve safety and efficacy. Enginprime is currently advancing clinical trials in China and planning for global regulatory submissions.

Therapeutic areas: Cardiovascular
Modalities: Device
Industry: Therapeutic Medical Devices

Beyond the preview

Go deeper on Enginprime Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Enginprime Medical.

Explore the full profile